CHICAGO--(BUSINESS WIRE)--Syntax Bio, a synthetic biology company programming next generation cell therapies, today announced a research and development collaboration with Mayo Clinic focused on ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Consumer Cellular will ...

A new nanoscopy technique developed at The Australian National University (Canberra, Australia) has uncovered hidden networks used for cell-to-cell communication, opening new ways to understand human ...

There are significant moments in counseling and psychotherapy that transcend the standard boundaries of the clinical contract. It is a precise instant when the formal roles of “practitioner” and ...

Getting a depth module in Subnautica 2 increases your tadpole submarine's depth resistance and lets you explore further without having to worry about finding oxygen spots. However, you'll reach the ...

Cellular Origins agreed to collaborate with Immatics in utilizing Cellular Origins’ automated mobile robotic platform, Constellation ®, within certain parts of the company’s manufacturing processes.

Cellares reported that the first two patients have been dosed with Cabaletta Bio’s investigational CAR T cell therapy rese-cel (resecabtagene autoleucel) manufactured on Cellares’ Cell Shuttle™ ...

First-in-human clinical trial underway to evaluate safety, tolerability and pharmacodynamic activity of HB2198 in normal healthy volunteers. A separate Phase 1 trial evaluating HB2198 in patients with ...

The FDA has delayed its target decision date for Orca Bio’s blood cancer cell therapy candidate Orca-T by three months to July 6. The review extension comes after the company submitted additional data ...

Photobiomodulation uses red and near-infrared light to modulate mitochondrial activity, cellular signaling, and inflammatory pathways, supporting tissue repair and physiological recovery. Clinical ...